Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: US MM Immunotherapy Consortium study suggests universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in myeloma, vs. FDA and EMA guidance of 8 weeks.”
Authors: Rahul Banerjee, Alicia Richards, Shonali Midha, Aimaz Afrough, Faiz Anwer, Thomas Martin, Peter Voorhees, Larry Anderson, Jr., Andrew Cowan, Gurbakhash Kaur et al.
More posts featuring Robert Orlowski.
